Givaudan | GIVN - Ebitda


Givaudan reported CHF778M in EBITDA for its fiscal semester ending in December of 2025.





Ebitda Change Date
Air Liquide EUR 4.22B 399.7M Jun/2026
Akzo Nobel EUR 398M 53M Jun/2026
Anheuser-Busch USD 5.94B 501M Jun/2026
Arkema EUR 390.9M 108.2M Jun/2026
Associated British Foods GBP 956M 136M Dec/2022
BASF EUR 2.45B 93M Jun/2026
Bayer EUR 2.14B 2.31B Jun/2026
Beiersdorf EUR 984M 147M Jun/2025
British American Tobacco GBP 6.02B 200M Jun/2024
Covestro EUR 117M 125M Dec/2025
Croda International GBP 198.5M 4.7M Jun/2025
Danone EUR 2.57B 116M Dec/2025
Diageo GBP 3.53B 229M Dec/2025
Fresenius EUR 988M 37M Jun/2026
Fresenius Medical Care EUR 824M 250M Mar/2026
Givaudan CHF 778M 195M Dec/2025
Heineken EUR 3.12B 195M Jun/2026
Henkel EUR 1.88B 139M Dec/2024
International Flavors Fragrances USD 548M 20M Jun/2026
Johnson Matthey GBP 325M 52M Jun/2024
Kerry EUR 558.1M 77.7M Jun/2026
Lonza CHF 1.01B 54M Dec/2025
L'Oréal EUR 5.11B 489.1M Dec/2025
Merck EUR 1.53B 87M Mar/2026
Nestle CHF 8.85B 239M Jun/2026
Pernod Ricard EUR 2.18B 997M Dec/2024
Reckitt Benckiser GBP 1.95B 708M Jun/2025
SGS CHF 774M 78M Dec/2024
Sika AG CHF 994.3M 76.1M Dec/2025
Solvay EUR 187M 32M Jun/2026
Tate & Lyle GBP 200M 15M Jun/2026
Umicore EUR 577M 163M Jun/2026
Victrex GBP 49.1M 4M Dec/2023